Inovio set to raise $36M following 'strategic refocus'

Inovio remains on track to seek approval for its lead drug candidate during the second half of this year.

Source: bizjournals.com Health Care:Biotechnology headlines - April 16, 2024 Category: Biotechnology Authors: John George Source Type: news